Jie Chen Selected Research

Indicators and Reagents (Reagents)

5/2023	Maximum Value on Arterial Phase Computed Tomography Predicts Prognosis and Treatment Efficacy of Sunitinib for Pancreatic Neuroendocrine Tumours.
1/2023	High blood galectin-3 level associated with risk of frailty in aging.
1/2023	Ascending aortic volume: A feasible indicator for ascending aortic aneurysm elective surgery?
1/2023	Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.
1/2022	Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency.
1/2022	High-Sensitivity Troponin I is an Indicator of Poor Prognosis in Patients with Severe COVID-19 Related Pneumonia.
10/2021	Excipient of paclitaxel induces metabolic dysregulation and unfolded protein response.
1/2021	Risk assessment of chronic obstructive pulmonary disease using a Bayesian network based on a provincial survey.
1/2021	Modeling multi-level survival data in multi-center epidemiological cohort studies: Applications from the ELAPSE project.
10/2020	Predictive value of adipose to muscle area ratio based on MRI at knee joint for postoperative functional outcomes in elderly osteoarthritis patients following total knee arthroplasty.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Chen Research Topics

Disease

830	Neoplasms (Cancer) 05/2024 - 04/2002
174	Inflammation (Inflammations) 04/2024 - 03/2002
171	Infections 04/2024 - 01/2002
171	Neoplasm Metastasis (Metastasis) 02/2024 - 05/2002
152	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 02/2003
112	Breast Neoplasms (Breast Cancer) 04/2024 - 07/2003
89	Fibrosis (Cirrhosis) 02/2024 - 03/2003
88	Carcinogenesis 03/2024 - 04/2002
58	Carcinoma (Carcinomatosis) 07/2023 - 01/2003
58	Stomach Neoplasms (Stomach Cancer) 02/2023 - 01/2003
53	Lung Neoplasms (Lung Cancer) 12/2024 - 04/2002
52	Hypoxia (Hypoxemia) 10/2023 - 04/2008
51	Pain (Aches) 05/2024 - 01/2009
48	Wounds and Injuries (Trauma) 04/2024 - 04/2006
45	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2024 - 01/2004
45	Obesity 03/2024 - 07/2007
42	Hypertension (High Blood Pressure) 02/2024 - 01/2003
42	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2005
42	Body Weight (Weight, Body) 11/2023 - 01/2005
39	Pneumonia (Pneumonitis) 04/2024 - 12/2008
38	Adenocarcinoma 05/2024 - 02/2002
37	Stroke (Strokes) 05/2024 - 07/2008
37	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 02/2002
35	Liver Neoplasms (Liver Cancer) 01/2023 - 06/2003
33	COVID-19 05/2024 - 01/2020
33	Thrombosis (Thrombus) 01/2024 - 08/2006
32	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 07/2004
32	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 10/2012
32	Insulin Resistance 04/2023 - 01/2008
31	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 02/2003
30	Type 2 Diabetes Mellitus (MODY) 04/2024 - 03/2002
30	Silicosis 10/2023 - 02/2004
30	Hemorrhage 09/2023 - 01/2005
29	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 03/2007
27	Non-alcoholic Fatty Liver Disease 02/2024 - 08/2009
26	Disease Progression 02/2024 - 02/2003
26	Necrosis 04/2023 - 07/2006
25	Lymphatic Metastasis 03/2024 - 01/2006
24	Sepsis (Septicemia) 04/2024 - 09/2012
24	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 11/2009
24	Leukemia 12/2023 - 06/2003
23	Adenocarcinoma of Lung 04/2024 - 04/2002
23	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 04/2009
22	Hepatitis B 03/2024 - 05/2010
21	Esophageal Squamous Cell Carcinoma 03/2024 - 01/2015
21	Parkinson Disease (Parkinson's Disease) 01/2024 - 02/2011
21	Asthma (Bronchial Asthma) 12/2023 - 08/2009
20	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 12/2003
20	Autism Spectrum Disorder 04/2024 - 09/2017
20	Cognitive Dysfunction 02/2024 - 01/2011
20	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 10/2009

Drug/Important Bio-Agent (IBA)

283	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2002
191	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2006
108	Messenger RNA (mRNA)IBA 04/2024 - 04/2002
76	MicroRNAs (MicroRNA)IBA 02/2024 - 12/2008
73	CytokinesIBA 03/2024 - 12/2003
63	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 03/2002
62	EnzymesIBA 04/2024 - 01/2003
61	RNA (Ribonucleic Acid)IBA 12/2023 - 06/2003
60	Long Noncoding RNAIBA 02/2024 - 01/2014
55	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 05/2002
50	LipidsIBA 05/2024 - 03/2012
43	AntigensIBA 03/2024 - 01/2009
40	Small Interfering RNA (siRNA)IBA 02/2024 - 05/2004
39	Therapeutic UsesIBA 04/2024 - 02/2004
34	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2024 - 08/2006
34	LigandsIBA 12/2023 - 06/2005
33	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
33	Indicators and Reagents (Reagents)IBA 05/2023 - 06/2003
32	CateninsIBA 04/2024 - 01/2011
31	Transcription Factors (Transcription Factor)IBA 04/2024 - 06/2005
31	Interleukin-6 (Interleukin 6)IBA 02/2024 - 12/2003
31	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 05/2004
31	CollagenIBA 12/2023 - 01/2002
30	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 07/2008
30	Silicon Dioxide (Silica)FDA LinkGeneric 10/2023 - 05/2009
29	Peptides (Polypeptides)IBA 04/2024 - 01/2003
29	Phosphotransferases (Kinase)IBA 02/2024 - 09/2005
28	Oxygen (Dioxygen)IBA 05/2024 - 11/2008
27	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2012
26	AntioxidantsIBA 01/2024 - 11/2004
25	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 01/2006
24	Insulin (Novolin)FDA Link 04/2024 - 03/2002
23	LipopolysaccharidesIBA 02/2024 - 12/2003
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 12/2003
22	ErbB Receptors (EGF Receptor)IBA 01/2024 - 01/2004
20	IronIBA 05/2024 - 12/2011
20	ParaffinIBA 04/2024 - 02/2002
20	Blood Glucose (Blood Sugar)IBA 03/2024 - 10/2016
20	CholesterolIBA 11/2023 - 12/2003
20	Circular RNAIBA 07/2023 - 04/2016
20	IodineIBA 01/2017 - 06/2005

Therapy/Procedure

380	Therapeutics 05/2024 - 01/2002
114	Drug Therapy (Chemotherapy) 03/2024 - 12/2004
70	Immunotherapy 05/2024 - 05/2010
67	Radiotherapy 03/2024 - 01/2005
26	Length of Stay 03/2024 - 10/2011
26	Aftercare (After-Treatment) 01/2024 - 06/2001
20	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 06/2005
20	Transplantation 01/2024 - 10/2005